Stock data
0.23% • 24 HSun Pharmaceutical Industries (SUNPHARMA) Stock Overview
Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology, neuropsychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It provides APIs for anti-cancers, peptides, steroids, hormones, and immunosuppressant drugs. In addition, the company offers generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, and anti retro viral medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.
SUNPHARMA Stock Information
Sun Pharmaceutical Industries (SUNPHARMA) Price Chart
Sun Pharmaceutical Industries Overview: Key Details and Summary
Stock data | 2023 | Change |
|---|---|---|
| Price | $18.16 | N/A |
| Market Cap | $43.58B | N/A |
| Shares Outstanding | 2.40B | -0.25% |
| Employees | 41.00K | N/A |
| Shareholder Equity | 593.15B | 16.15% |
Valuation | 2023 | Change |
|---|---|---|
| P/E Ratio | 0.51 | N/A |
| P/S Ratio | 8.41 | N/A |
| P/B Ratio | 0.07 | N/A |
| P/FCF | 126.68 | N/A |
Dividends | 2023 | Change |
|---|---|---|
| Dividend Yield | 0.69% | N/A |
| Dividend per share | 0.1256 | N/A |
| Dividend Payout Ratio | 0.2959 | N/A |
Growth | 2023 | Change |
|---|---|---|
| ROIC | 0.1087 | N/A |
| CAPEX | -247.16M | N/A |
| Return on Equity | 0.0017 | N/A |
Earnings | 2023 | Change |
|---|---|---|
| Revenue | $5.18B | N/A |
| Earnings | $1.02B | N/A |
| Free Cash Flow | $344.04M | N/A |
| EPS | 35.30 | N/A |
| Earnings Yield | 1.94 | N/A |
| Gross Margin | 0.7536 | N/A |
| Operating Margin | 0.2136 | N/A |
| Net income margin | 0.1967 | N/A |
| FCF Margin | 0.0664 | N/A |
Financial Strength | 2023 | Change |
|---|---|---|
| Total Assets | $9.67B | N/A |
| Total Debt | $824.81M | N/A |
| Cash on Hand | $1.90B | N/A |
| Debt to Equity | 0.0043 | -1.53% |
| Cash to Debt | $2.31 | -76.46% |
| Current Ratio | $2.00 | -1.58% |
Other data | 2023 | Change |
|---|---|---|
| Buyback Yield | 0.0000 | N/A |
